Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

September 10, 2020

Serum Exosomal miR-17-5p as a Promising Biomarker Diagnostic Biomarker for Breast Cancer

Clinical Laboratory
Shanmei LvXuejun Dong
September 11, 2020
Open Access

Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential

Stem Cells International
Ashley G ZhaoHuseyin Sumer
September 10, 2020
Open Access

Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?

International Journal of Molecular Sciences
Stefano MartellucciSilvia Zappavigna
September 8, 2020

MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis

Cancer Biomarkers : Section a of Disease Markers
Xuan ZouWei Zhu
September 14, 2020

Urinary biomarkers in bladder cancer: A review of the current landscape and future directions

Urologic Oncology
Kenrick NgNikhil Vasdev
September 13, 2020

Exosomes: A Source for New and Old Biomarkers in Cancer

Mariantonia LogozziStefano Fais
September 9, 2020

Exosomal noncoding RNAs in colorectal cancer

Cancer Letters
Qingbin WuYong Peng
September 9, 2020
Open Access

Role of exosomes in malignancies

Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti
M VodičkováS Ševčíková
September 10, 2020

cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?

Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology
Tomasz KolendaKatarzyna Lamperska
September 10, 2020

Advances in exosome analysis methods with an emphasis on electrochemistry

Analytical Chemistry
Ayemeh Bagheri HashkavayiKi Soo Park

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved